Beyond PI3Ks: targeting phosphoinositide kinases in disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.nature.com/articles/s41573-022-00582-5.pdf
Reference292 articles.
1. Balla, T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 93, 1019–1137 (2013).
2. Dickson, E. J. & Hille, B. Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids. Biochem. J. 476, 1–23 (2019).
3. Schink, K. O., Tan, K.-W. & Stenmark, H. Phosphoinositides in control of membrane dynamics. Annu. Rev. Cell Dev. Biol. 32, 143–171 (2016).
4. Hasegawa, J., Strunk, B. S. & Weisman, L. S. PI5P and PI(3,5)P2: minor, but essential phosphoinositides. Cell Struct. Funct. 42, 49–60 (2017).
5. Gozzelino, L., De Santis, M. C., Gulluni, F., Hirsch, E. & Martini, M. PI(3,4)P2 signaling in cancer and metabolism. Front. Oncol. 10, 360 (2020).
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine;Journal of Ethnopharmacology;2024-11
2. Mammalian START-like phosphatidylinositol transfer proteins – Physiological perspectives and roles in cancer biology;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-10
3. Molecular basis of product recognition during PIP5K-mediated production of PI(4,5)P2 with positive feedback;Journal of Biological Chemistry;2024-09
4. Loss of PI5P4Kα slows the progression of aPtenmutant basal cell model of prostate cancer;2024-08-12
5. Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: The mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway;Journal of Ethnopharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3